- Home
- ORGO vs ESOA Comparison
ORGO vs ESOA Comparison
Compare ORGO & ESOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORGO | ESOA |
|---|---|---|
| Founded | 1985 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Water Sewer Pipeline Comm & Power Line Construction |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.8M | 314.2M |
| IPO Year | 2016 | 2006 |
Fundamental Metrics
Financial Performance| Metric | ORGO | ESOA |
|---|---|---|
| Price | $2.52 | $15.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $8.50 | ★ $21.00 |
| AVG Volume (30 Days) | ★ 937.0K | 171.3K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 0.74% |
| EPS Growth | ★ 1600.00 | N/A |
| EPS | N/A | ★ 0.17 |
| Revenue | ★ $564,169,000.00 | $122,465,826.00 |
| Revenue This Year | N/A | $9.22 |
| Revenue Next Year | $26.27 | $3.77 |
| P/E Ratio | ★ N/A | $90.88 |
| Revenue Growth | ★ 17.04 | 2.74 |
| 52 Week Low | $2.04 | $7.84 |
| 52 Week High | $7.08 | $19.94 |
Technical Indicators
Market Signals| Indicator | ORGO | ESOA |
|---|---|---|
| Relative Strength Index (RSI) | 51.37 | 45.30 |
| Support Level | $2.20 | $14.73 |
| Resistance Level | $2.67 | $15.84 |
| Average True Range (ATR) | 0.14 | 0.84 |
| MACD | -0.01 | -0.24 |
| Stochastic Oscillator | 62.12 | 20.90 |
Price Performance
Historical ComparisonAbout ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About ESOA Energy Services of America Corporation
Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.